These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 1710772)
1. Secretion and transcriptional regulation of transforming growth factor-beta 3 during myogenesis. Lafyatis R; Lechleider R; Roberts AB; Sporn MB Mol Cell Biol; 1991 Jul; 11(7):3795-803. PubMed ID: 1710772 [TBL] [Abstract][Full Text] [Related]
2. A GC-rich domain with bifunctional effects on mRNA and protein levels: implications for control of transforming growth factor beta 1 expression. Scotto L; Assoian RK Mol Cell Biol; 1993 Jun; 13(6):3588-97. PubMed ID: 8497272 [TBL] [Abstract][Full Text] [Related]
3. Transcriptional activation of transforming growth factor-beta1 in mesangial cell culture by high glucose concentration. Hoffman BB; Sharma K; Zhu Y; Ziyadeh FN Kidney Int; 1998 Oct; 54(4):1107-16. PubMed ID: 9767526 [TBL] [Abstract][Full Text] [Related]
4. Nerve growth factor induces transcription of transforming growth factor-beta 1 through a specific promoter element in PC12 cells. Kim SJ; Park K; Rudkin BB; Dey BR; Sporn MB; Roberts AB J Biol Chem; 1994 Feb; 269(5):3739-44. PubMed ID: 8106419 [TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of the chicken transforming growth factor-beta 3 promoter. Jakowlew SB; Lechleider R; Geiser AG; Kim SJ; Santa-Coloma TA; Cubert J; Sporn MB; Roberts AB Mol Endocrinol; 1992 Aug; 6(8):1285-98. PubMed ID: 1406706 [TBL] [Abstract][Full Text] [Related]
6. Proliferin, a prolactin/growth hormone-like peptide represses myogenic-specific transcription by the suppression of an essential serum response factor-like DNA-binding activity. Muscat GE; Gobius K; Emery J Mol Endocrinol; 1991 Jun; 5(6):802-14. PubMed ID: 1656242 [TBL] [Abstract][Full Text] [Related]
7. miR-22 regulates C2C12 myoblast proliferation and differentiation by targeting TGFBR1. Wang H; Zhang Q; Wang B; Wu W; Wei J; Li P; Huang R Eur J Cell Biol; 2018 May; 97(4):257-268. PubMed ID: 29588073 [TBL] [Abstract][Full Text] [Related]
8. Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors. Allen DL; Unterman TG Am J Physiol Cell Physiol; 2007 Jan; 292(1):C188-99. PubMed ID: 16885393 [TBL] [Abstract][Full Text] [Related]
9. Cell adhesion to collagen and decreased myogenic gene expression implicated in the control of myogenesis by transforming growth factor beta. Heino J; Massagué J J Biol Chem; 1990 Jun; 265(18):10181-4. PubMed ID: 2162338 [TBL] [Abstract][Full Text] [Related]
10. Polyomavirus genome and polyomavirus enhancer-driven gene expression during myogenesis. Maione R; Felsani A; Pozzi L; Caruso M; Amati P J Virol; 1989 Nov; 63(11):4890-7. PubMed ID: 2552161 [TBL] [Abstract][Full Text] [Related]
11. cis-acting sequences of the rat troponin I slow gene confer tissue- and development-specific transcription in cultured muscle cells as well as fiber type specificity in transgenic mice. Banerjee-Basu S; Buonanno A Mol Cell Biol; 1993 Nov; 13(11):7019-28. PubMed ID: 8413291 [TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism of transforming growth factor-beta-mediated inhibition of growth arrest and differentiation in a myoblast cell line. Murakami M; Ohkuma M; Nakamura M Dev Growth Differ; 2008 Feb; 50(2):121-30. PubMed ID: 18211587 [TBL] [Abstract][Full Text] [Related]
13. Identification of a transforming growth factor-beta1/bone morphogenetic protein 4 (TGF-beta1/BMP4) response element within the mouse tissue transglutaminase gene promoter. Ritter SJ; Davies PJ J Biol Chem; 1998 May; 273(21):12798-806. PubMed ID: 9582307 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the mouse transforming growth factor-beta 1 promoter and activation by the Ha-ras oncogene. Geiser AG; Kim SJ; Roberts AB; Sporn MB Mol Cell Biol; 1991 Jan; 11(1):84-92. PubMed ID: 1986255 [TBL] [Abstract][Full Text] [Related]
15. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells. Kutz SM; Providence KM; Higgins PJ Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948 [TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids coordinately regulate type I collagen pro alpha 1 promoter activity through both the glucocorticoid and transforming growth factor beta response elements: a novel mechanism of glucocorticoid regulation of eukaryotic genes. Meisler N; Shull S; Xie R; Long GL; Absher M; Connolly JP; Cutroneo KR J Cell Biochem; 1995 Nov; 59(3):376-88. PubMed ID: 8567755 [TBL] [Abstract][Full Text] [Related]
18. Post-transcriptional regulation of the human transforming growth factor-beta 1 gene. Kim SJ; Park K; Koeller D; Kim KY; Wakefield LM; Sporn MB; Roberts AB J Biol Chem; 1992 Jul; 267(19):13702-7. PubMed ID: 1618868 [TBL] [Abstract][Full Text] [Related]
19. Betaglycan expression is transcriptionally up-regulated during skeletal muscle differentiation. Cloning of murine betaglycan gene promoter and its modulation by MyoD, retinoic acid, and transforming growth factor-beta. Lopez-Casillas F; Riquelme C; Perez-Kato Y; Ponce-Castaneda MV; Osses N; Esparza-Lopez J; Gonzalez-Nunez G; Cabello-Verrugio C; Mendoza V; Troncoso V; Brandan E J Biol Chem; 2003 Jan; 278(1):382-90. PubMed ID: 12399463 [TBL] [Abstract][Full Text] [Related]
20. Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2. Kim SJ; Wagner S; Liu F; O'Reilly MA; Robbins PD; Green MR Nature; 1992 Jul; 358(6384):331-4. PubMed ID: 1641004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]